We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$329B
AUM Growth
+$18.7B
Cap. Flow
+$4.79B
Cap. Flow %
1.46%
Top 10 Hldgs %
17.35%
Holding
3,654
New
108
Increased
2,088
Reduced
988
Closed
104

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.91B
2
UPS icon
United Parcel Service
UPS
+$1.86B
3
CVX icon
Chevron
CVX
+$1.72B
4
BX icon
Blackstone
BX
+$904M
5
F icon
Ford
F
+$722M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.64B
2
PRU icon
Prudential Financial
PRU
+$553M
3
GPC icon
Genuine Parts
GPC
+$543M
4
CMI icon
Cummins
CMI
+$538M
5
HIG icon
Hartford Financial Services
HIG
+$376M

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Healthcare 13.03%
3 Financials 11.86%
4 Consumer Discretionary 9.84%
5 Industrials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNTH icon
3501
Dianthus Therapeutics
DNTH
$5.84B
$21.8K ﹤0.01%
1,711
AXDX
3502
DELISTED
Accelerate Diagnostics
AXDX
$21.4K ﹤0.01%
3,051
HYPR icon
3503
Hyperfine
HYPR
$92.9M
$21.1K ﹤0.01%
14,647
-21,438
-59% -$26.2K
BYFC icon
3504
Broadway Financial
BYFC
$93.8M
$21.1K ﹤0.01%
2,507
CLSD
3505
DELISTED
Clearside Biomedical
CLSD
$21K ﹤0.01%
1,348
SFE
3506
DELISTED
Safeguard Scientifics, Inc.
SFE
$21K ﹤0.01%
12,218
MOVE icon
3507
Corvex Inc
MOVE
$299M
$20.6K ﹤0.01%
152
POL
3508
DELISTED
Polished.com Inc.
POL
$20.4K ﹤0.01%
786
AKU
3509
DELISTED
Akumin Inc
AKU
$20K ﹤0.01%
29,384
VIRX
3510
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$19.8K ﹤0.01%
12,430
ADN
3511
DELISTED
Advent Technologies
ADN
$19.2K ﹤0.01%
605
RCAT icon
3512
Red Cat Holdings
RCAT
$1.15B
$19.1K ﹤0.01%
18,398
ZFOX
3513
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$18.9K ﹤0.01%
12,914
MIRO
3514
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$18.5K ﹤0.01%
11,036
BNED icon
3515
Barnes & Noble Education
BNED
$431M
$18.1K ﹤0.01%
119
-14,403
-99% -$2.9M
BOXL icon
3516
Boxlight
BOXL
$2.03M
$18K ﹤0.01%
33
QNCX icon
3517
Quince Therapeutics
QNCX
$22.9M
$17.2K ﹤0.01%
55
GPUS
3518
Hyperscale Data Inc
GPUS
$55.4M
$17.1K ﹤0.01%
1
BZFD icon
3519
BuzzFeed
BZFD
$99M
$16.9K ﹤0.01%
3,749
CODX
3520
Co-Diagnostics
CODX
$5.31M
$16.4K ﹤0.01%
369
KSCP icon
3521
Knightscope
KSCP
$28.3M
$16.2K ﹤0.01%
364
ZYNE
3522
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$16.2K ﹤0.01%
37,596
LPCN icon
3523
Lipocine
LPCN
$17.5M
$15.9K ﹤0.01%
2,941
SYBX
3524
DELISTED
Synlogic
SYBX
$15.8K ﹤0.01%
1,667
BFX
3525
DELISTED
BowFlex Inc.
BFX
$15.4K ﹤0.01%
11,457

Similar funds

Charles Schwab's Q1 2023 Portfolio in Review

As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
  • Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
  • Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
  • Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
  • Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
  • Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
  • Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.